Revance Therapeutics shares owned by Mercer Global Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Mercer Global Advisors
from 13F filings
Historical chart of Mercer Global Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Mercer Global Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $159k | 18k | 8.80 |
| 2023-09-30 | $208k | 18k | 11.49 |
| 2023-06-30 | $232k | 9.2k | 25.32 |
| 2023-03-31 | $292k | 9.1k | 32.23 |
| 2022-12-31 | $205k | 11k | 18.48 |
| 2022-09-30 | $292k | 11k | 27.02 |
| 2022-06-30 | $148k | 11k | 13.79 |
| 2022-03-31 | $248k | 13k | 19.48 |
| 2021-12-31 | $334k | 21k | 16.32 |
| 2021-09-30 | $656k | 24k | 27.85 |
| 2021-06-30 | $698k | 24k | 29.64 |
| 2021-03-31 | $790k | 28k | 27.96 |
| 2020-12-31 | $875k | 31k | 28.35 |